Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model Full Text
BMC Cancer, 05/15/2012
Clinical Article
Wang C et al. – The combination of rapamycin with bortezomib could be a novel and promising therapeutic approach to the treatment of hepatocellular carcinoma (HCC).



